Search
Now showing items 1-10 of 642
-
Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China
(2020-02-27)OBJECTIVE. Confronting the new coronavirus infection known as coronavirus disease 2019 (COVID-19) is challenging and requires excluding patients with suspected COVID-19 who actually have other diseases. The purpose of this ... -
Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals
(2020-03-16)In December 2019, a novel coronavirus (CoV) epidemic, caused by the severe acute respiratory syndrome coronavirus - 2 (SARS-CoV-2) emerged from China. This virus causes the coronavirus disease 2019 (COVID-19). Since then, ... -
Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression.
(2020-03-06)OBJECTIVES: To explore the epidemiological information, clinical characteristics, therapeutic outcomes and temporal progression of laboratory findings in 2019-coronavirus disease (COVID-19) patients exposed to lopinavir. ... -
What Is Needed to Make Interventional Radiology Ready for COVID-19? Lessons from SARS-CoV Epidemic
(2020-03-13)Dear Editor, We read with interest an article on novel coronavirus disease 2019 (COVID-19) recently published in the journal by Lin et al.. In this letter, we hope to provide some insights from an interventional radiologist ... -
Ethics guidance on key issues raised by the novel coronavirus disease (COVID-19) pandemic, 16 March 2020
(2020-03-18)Health authorities are tasked with protecting the health of the population and responding to public health emergencies. An adequate health response to public health emergencies, such as the current WHO-declared COVID-19 ... -
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
(2020-03-18)BACKGROUND: No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2. METHODS: We conducted a randomized, controlled, open-label trial involving hospitalized adult patients ... -
Care of haematology patients in a COVID‐19 epidemic
(2020-03-15)The threat to health of the COVID‐19 infection (caused by the novel zoonotic SARS‐CoV‐2 coronavirus) is now established.1, 2 As widespread community transmission becomes likely, it is necessary to urgently consider the ... -
Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020
(2020-03-19)The cumulative incidence of coronavirus disease (COVID-19) cases is showing similar trends in European Union/European Economic Area countries and the United Kingdom confirming that, while at a different stage depending on ... -
What we know so far: COVID-19 current clinical knowledge and research
(2020-03-18)In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, ...